Zanamivir
CAS No. 139110-80-8
Zanamivir ( GG 167 | GR 121167X | Relenza )
产品货号. M11621 CAS No. 139110-80-8
Zanamivir 是一种高效、广谱的流感病毒神经氨酸酶 (NA) 抑制剂,对甲型流感和乙型流感的 IC50 值分别为 0.95 nM 和 2.7 nM。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥155 | 有现货 |
|
| 10MG | ¥250 | 有现货 |
|
| 25MG | ¥362 | 有现货 |
|
| 50MG | ¥491 | 有现货 |
|
| 100MG | ¥709 | 有现货 |
|
| 200MG | ¥1044 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Zanamivir
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Zanamivir 是一种高效、广谱的流感病毒神经氨酸酶 (NA) 抑制剂,对甲型流感和乙型流感的 IC50 值分别为 0.95 nM 和 2.7 nM。
-
产品描述Zanamivir is a hihly potent, broad-spetrum influenza viral neuraminidase (NA) inhibitor with IC50 of 0.95 nM and 2.7 nM for influenza A and B, respectively; inhibits plaque formation by laboratory-passaged strains of influenza A and B viruses,IC50 ranging from 0.005 to 0.014 uM; interacts with a group of amino acids in the active site of neuraminidase, which are conserved in all influenza A and B strains. Zanamivir blocks the action of neuraminidase, which prevents the cleavage of sialic acid on the cell receptors, thus preventing release and spread of the newly formed virions.Influenza Approved(In Vitro):Zanamivir interacts with a group of amino acids in the active site of neuraminidase, which are conserved in all influenza A and B strains. Zanamivir blocks the action of neuraminidase, which prevents the cleavage of sialic acid on the cell receptors, thus preventing release and spread of the newly formed virions.(In Vivo):Zanamivir has a poor bioavailability in oral administration, with only 4–17% of the agent. Oral delivery of zanamivir has been a problem due to its strong hydrophilic nature that limits its transport across the intestinal epithelium. Permeation enhancers such as sodium cholate, hydroxypropyl β-cyclodextrin could be used with zanamivir to enhance the intestinal permeability.
-
体外实验Zanamivir interacts with a group of amino acids in the active site of neuraminidase, which are conserved in all influenza A and B strains. Zanamivir blocks the action of neuraminidase, which prevents the cleavage of sialic acid on the cell receptors, thus preventing release and spread of the newly formed virions.
-
体内实验Zanamivir has a poor bioavailability in oral administration, with only 4–17% of the agent. Oral delivery of zanamivir has been a problem due to its strong hydrophilic nature that limits its transport across the intestinal epithelium. Permeation enhancers such as sodium cholate, hydroxypropyl β-cyclodextrin could be used with zanamivir to enhance the intestinal permeability.
-
同义词GG 167 | GR 121167X | Relenza
-
通路Microbiology/Virology
-
靶点Influenza Virus
-
受体InfluenzaA|InfluenzaB
-
研究领域Infection
-
适应症Influenza
化学信息
-
CAS Number139110-80-8
-
分子量332.3098
-
分子式C12H20N4O7
-
纯度>98% (HPLC)
-
溶解度H2O: ≥ 33.33 mg/mL
-
SMILESCC(=O)N[C@@H]1[C@H](C=C(O[C@H]1[C@@H]([C@@H](CO)O)O)C(=O)O)N=C(N)N
-
化学全称D-glycero-D-galacto-Non-2-enonic acid, 5-(acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Woods JM, et al. Antimicrob Agents Chemother. 1993 Jul;37(7):1473-9.
2. Gubareva LV, et al. Antimicrob Agents Chemother. 2001 Dec;45(12):3403-8.
3. McKimm-Breschkin JL, et al. Treat Respir Med. 2005;4(2):107-16.
4. Ryan DM, et al. Antimicrob Agents Chemother. 1994 Oct;38(10):2270-5.
021-51111890
购物车()
sales@molnova.cn

